Literature DB >> 14570891

Transcriptional regulation of insulin-like growth factor-I by interferon-gamma requires STAT-5b.

Vivian Hwa1, Brian Little, Eric M Kofoed, Ron G Rosenfeld.   

Abstract

Insulin-like growth factor (IGF)-I, a growth factor important for cell proliferation, cellular differentiation, and multiple metabolic functions, is regulated in vivo by growth factors and cytokines, but the mechanism(s) of regulation at the cellular level is not well understood. We now demonstrate, employing primary human dermal fibroblasts (CF), that the multipotent cytokine, interferon-gamma (IFN-gamma), can up-regulate IGF-I mRNA expression and that this regulation occurs via activation of the signal transducer and activator of transcription-5b (STAT-5b) pathway. IFN-gamma (100 units/ml) treatment of CF cells resulted in a preferential, time-dependent activation of STAT-5b, although both STAT-5a and STAT-5b isoforms are present. The activated STAT-5b translocated to the nucleus within 30 min of treatment and induced an increase in IGF-I mRNA of 6 +/- 1.0-fold, 3 h post-treatment, with a further increase to 8 +/- 1.7-fold at 5 h. In contrast, IFN-gamma treatment of primary human dermal fibroblasts with a nonfunctional STAT-5b (PF cells) resulted in activation of only STAT-5a and an increase of the IGF-I mRNA level of 1.7 +/- 0.6-fold, 5 h post-treatment. The IFN-gamma-induced regulation of the interferon regulatory factor-1 gene, whose expression is dependent on activated STAT-1, was the same between CF and PF cells. In summary, our results provide evidence of the following in human primary dermal fibroblasts: (a). IFN-gamma preferentially activates STAT-5b, but, in the absence of a functional STAT-5b, STAT-5a is activated; (b). IFN-gamma time-dependently up-regulates IGF-I mRNA expression; (c). the regulation of IGF-I requires an active STAT-5b, and activated STAT-5a cannot substitute for an inactive STAT-5b; and (d). STAT-5b has an essential role in the transcriptional up-regulation of IGF-I.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14570891     DOI: 10.1074/jbc.M310495200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

Review 1.  Identification of the first patient with a confirmed mutation of the JAK-STAT system.

Authors:  Ron G Rosenfeld; Eric Kofoed; Caroline Buckway; Brian Little; Katie A Woods; Junko Tsubaki; Katherine A Pratt; Liliana Bezrodnik; Hector Jasper; Alejandro Tepper; Juan J Heinrich; Vivian Hwa
Journal:  Pediatr Nephrol       Date:  2005-02-02       Impact factor: 3.714

2.  Effects of alpha-interferon on insulin-like growth factor-I, insulin-like growth factor-II and insulin-like growth factor binding protein-3 secretion by a human lung cancer cell line in vitro.

Authors:  P Del Monte; C Laurino; M Arvigo; C Palermo; F Minuto; A Barreca
Journal:  J Endocrinol Invest       Date:  2005-05       Impact factor: 4.256

3.  Targeting the insulin growth factor and the vascular endothelial growth factor pathways in ovarian cancer.

Authors:  Minghai Shao; Stacy Hollar; Daphne Chambliss; Jordan Schmitt; Robert Emerson; Bhadrani Chelladurai; Susan Perkins; Mircea Ivan; Daniela Matei
Journal:  Mol Cancer Ther       Date:  2012-06-13       Impact factor: 6.261

4.  RNAi targeting CXCR4 inhibits tumor growth through inducing cell cycle arrest and apoptosis.

Authors:  Tao Yu; Yingying Wu; Yi Huang; Chaoran Yan; Ying Liu; Zongsheng Wang; Xiaoyi Wang; Yuming Wen; Changmei Wang; Longjiang Li
Journal:  Mol Ther       Date:  2011-11-22       Impact factor: 11.454

5.  Novel microcephalic primordial dwarfism disorder associated with variants in the centrosomal protein ninein.

Authors:  Andrew Dauber; Stephen H Lafranchi; Zoltan Maliga; Julian C Lui; Jennifer E Moon; Cailin McDeed; Katrin Henke; Jonathan Zonana; Garrett A Kingman; Tune H Pers; Jeffrey Baron; Ron G Rosenfeld; Joel N Hirschhorn; Matthew P Harris; Vivian Hwa
Journal:  J Clin Endocrinol Metab       Date:  2012-08-29       Impact factor: 5.958

6.  IGFBP-3 sensitizes prostate cancer cells to interferon-gamma-induced apoptosis.

Authors:  Peng Fang; Vivian Hwa; Brian M Little; Ron G Rosenfeld
Journal:  Growth Horm IGF Res       Date:  2007-08-24       Impact factor: 2.372

7.  A functional and regulatory network associated with PIP expression in human breast cancer.

Authors:  Marie-Anne Debily; Sandrine El Marhomy; Virginie Boulanger; Eric Eveno; Régine Mariage-Samson; Alessandra Camarca; Charles Auffray; Dominique Piatier-Tonneau; Sandrine Imbeaud
Journal:  PLoS One       Date:  2009-03-05       Impact factor: 3.240

Review 8.  STAT5B deficiency: Impacts on human growth and immunity.

Authors:  Vivian Hwa
Journal:  Growth Horm IGF Res       Date:  2015-12-10       Impact factor: 2.372

Review 9.  Cytokine inhibition of JAK-STAT signaling: a new mechanism of growth hormone resistance.

Authors:  Charles H Lang; Ly Hong-Brown; Robert A Frost
Journal:  Pediatr Nephrol       Date:  2004-11-10       Impact factor: 3.714

Review 10.  Genetic causes of growth hormone insensitivity beyond GHR.

Authors:  Vivian Hwa; Masanobu Fujimoto; Gaohui Zhu; Wen Gao; Corinne Foley; Meenasri Kumbaji; Ron G Rosenfeld
Journal:  Rev Endocr Metab Disord       Date:  2020-10-08       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.